These findings demonstrate that PIK3C2B promotes a hypermetabolic state by coordinately enhancing mitochondrial oxidative capacity, glycolytic reserve, and expression of critical metabolic enzymes, thereby increasing bioenergetic adaptability in lung cancer cells. Here, PIK3C2B is linked to lung carcinoma.